Alzheimer’s Disease-Related Proteins Targeted by Secondary Metabolite Compounds from A Scoping Review
Background: Alzheimer’s disease (AD) is a neurodegenerative disease that is characterized as rapid and progressive cognitive decline affecting 26 million people worldwide. Although immunotherapies are ideal, its clinical safety and effectiveness are controversial, hence, treatments are still reliant...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publishing
2023-12-01
|
| Edice: | Journal of Alzheimer's Disease Reports |
| On-line přístup: | https://doi.org/10.3233/ADR-230065 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|